Oral Anticoagulants - Utilisation and Expenditure under the Community Drugs Schemes.
Ir Med J
; 113(5): 71, 2020 05 07.
Article
em En
| MEDLINE
| ID: mdl-32603567
ABSTRACT
Aims This study determined the impact of the direct oral anticoagulants (DOACs) on the utilisation and expenditure on oral anticoagulants (OACs) in the Irish Community healthcare setting. We also investigated aspects of DOAC prescribing. Methods Using anonymised prescription data from the HSE pharmacy claims database we investigated anticoagulant prescribing over the study period (1/1/2014 - 31/12/2018). Results Some 74,748 patients were being treated with OACs by the year end 2018 an increase of 30,319 over 5 years. Warfarin prescribing fell from 32,751 patients in 2014 to 16,166 by the year end 2018. Apixaban is the most frequently prescribed OAC and annual expenditure on DOACs now exceeds 51 million. Patients treated with DOACs are older than participants in the pivotal clinical trials and are frequently co-administered interacting drugs. Conclusion The introduction of DOACs has resulted in an overall increase in anticoagulant prescribing, a significant reduction in warfarin usage and a large increase in expenditure.
Buscar no Google
Temas:
ECOS
/
Aspectos_gerais
/
Estado_mercado_regulacao
/
Financiamentos_gastos
Bases de dados:
MEDLINE
Assunto principal:
Prescrições de Medicamentos
/
Gastos em Saúde
/
Revisão de Uso de Medicamentos
/
Serviços de Saúde Comunitária
/
Uso de Medicamentos
/
Anticoagulantes
Tipo de estudo:
Diagnostic_studies
/
Health_economic_evaluation
Limite:
Humans
País/Região como assunto:
Europa
Idioma:
En
Revista:
Ir Med J
Ano de publicação:
2020
Tipo de documento:
Article